Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aileron Therapeutics (ALRN – Research Report) and OrthoPediatrics (KIDS – Research Report).
Aileron Therapeutics (ALRN)
H.C. Wainwright analyst Edward White maintained a Hold rating on Aileron Therapeutics today. The company’s shares closed last Tuesday at $0.20, close to its 52-week low of $0.13.
According to TipRanks.com, White has 0 stars on 0-5 stars ranking scale with an average return of
The the analyst consensus on Aileron Therapeutics is currently a Hold rating.
See today’s best-performing stocks on TipRanks >>
OrthoPediatrics (KIDS)
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on OrthoPediatrics, with a price target of $62.00. The company’s shares closed last Tuesday at $37.36, close to its 52-week low of $36.71.
According to TipRanks.com, Zimmerman is a 4-star analyst with an average return of
Currently, the analyst consensus on OrthoPediatrics is a Strong Buy with an average price target of $61.20, a 52.6% upside from current levels. In a report issued on October 17, Truist Financial also maintained a Buy rating on the stock with a $52.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ALRN:
